Condyloma acuminatum
Conditions
Interventions
Retinoic acid group:Oral administration of (all trans) tretinoin tablets (10mg po tid) for 2 weeks, followed by electrocautery at the rash site and subcutaneous injection of interleukin-2 (1 million u
Sponsors
The Second Affiliated Hospital of Guangxi Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. Age >= 18 years old 2. Condyloma acuminatum was diagnosed as primary and no reinfection, no other sexually transmitted diseases, no immunosuppressive constitution (such as autoimmune diseases, diabetes, tumors, transplantation, history of long-term use of antibiotics, glucocorticoids, immunosuppressants, biological agents, JAK inhibitors, chemotherapy drugs, targeted drugs and other medical history), and no other drugs were used during the treatment period; Patients who have no history of using antiviral or anti-tumor drugs before treatment and agree to use (all trans) retinoic acid tablets. 3. No history of allergy to (all trans) retinoic acid tablets or contraindications to the use of (all trans) retinoic acid tablets. 4. Agree to participate in the follow-up and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with other serious complications that may affect the assessment or treatment of their condition. 2. Individuals with mental illnesses; Those who cannot insist on re examination. Patients who are unable to use strict contraception during treatment and those who are unable to use strict contraception after stopping medication for one year. Recent exposure to sunlight and long-term alcohol consumption cannot avoid drinkers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Therapeutic effect on warts; | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse reactions; | — |
Countries
China
Contacts
Public ContactLulu Tang
The Second Affiliated Hospital of Guangxi Medical University
Outcome results
None listed